Intercytex Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

Intercytex General Information

Description

Developer of cell therapy technology designed for the development of innovative regenerative medicine products. The company's technology utilizes injectable human dermal fibroblasts suspended in a cell storage medium that remodel skin and promote collagen and extracellular matrix formation within the dermis, enabling patients with epidermolysis bullosa, scar contractures, acne scarring, and related skin conditions to improve overall skin function through a less invasive regenerative treatment approach.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Innovation House
  • Crewe Road
  • Manchester M23 9QR
  • England, United Kingdom
+44 0161
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Biotechnology
Corporate Office
  • Innovation House
  • Crewe Road
  • Manchester M23 9QR
  • England, United Kingdom
+44 0161

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intercytex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 12-Dec-2023 Completed Out of Business
4. IPO 30-Jun-2010 Completed Clinical Trials - Phase 1
3. Later Stage VC 01-Aug-2005 Completed Generating Revenue
2. Early Stage VC 01-Aug-2003 $1.62M $1.62M Completed Startup
1. University Spin-Out 25-Feb-1999 Completed Startup
To view Intercytex’s complete valuation and funding history, request access »

Intercytex Patents

Intercytex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201413535-D0 Culture Inactive 30-Jul-2014
GB-0920680-D0 Composition Inactive 25-Nov-2009
GB-0906301-D0 Culture Inactive 09-Apr-2009
GB-0906302-D0 Culture Inactive 09-Apr-2009
GB-0906303-D0 Culture Inactive 09-Apr-2009
To view Intercytex’s complete patent history, request access »

Intercytex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intercytex FAQs

  • When was Intercytex founded?

    Intercytex was founded in 1999.

  • Where is Intercytex headquartered?

    Intercytex is headquartered in Manchester, United Kingdom.

  • What is the size of Intercytex?

    Intercytex has 6 total employees.

  • What industry is Intercytex in?

    Intercytex’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Intercytex a private or public company?

    Intercytex is a Private company.

  • What is Intercytex’s current revenue?

    The current revenue for Intercytex is .

  • How much funding has Intercytex raised over time?

    Intercytex has raised $38.6M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process